Holocene Advisors’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-65,954
Closed -$1.09M 823
2022
Q3
$1.09M Sell
65,954
-14,586
-18% -$294K 0.01% 595
2022
Q2
$1.69M Buy
80,540
+67,215
+504% +$1.37M 0.01% 588
2022
Q1
$313K Sell
13,325
-13,926
-51% -$341K ﹤0.01% 800
2021
Q4
$741K Buy
27,251
+853
+3% +$22.8K ﹤0.01% 720
2021
Q3
$750K Sell
26,398
-78,829
-75% -$2.4M ﹤0.01% 718
2021
Q2
$3.17M Sell
105,227
-54,684
-34% -$1.61M 0.02% 464
2021
Q1
$4.07M Buy
159,911
+87,436
+121% +$2.24M 0.03% 440
2020
Q4
$1.78M Buy
72,475
+44,846
+162% +$842K 0.01% 445
2020
Q3
$450K Buy
+27,629
New +$514K ﹤0.01% 587
2020
Q2
Sell
-58,181
Closed -$677K 712
2020
Q1
$677K Sell
58,181
-9,296
-14% -$192K 0.01% 501
2019
Q4
$1.88M Sell
67,477
-4,617
-6% -$116K 0.02% 422
2019
Q3
$1.63M Buy
72,094
+31,315
+77% +$714K 0.02% 361
2019
Q2
$1.03M Buy
40,779
+16,593
+69% +$446K 0.01% 279
2019
Q1
$657K Buy
+24,186
New +$811K 0.01% 354
2018
Q4
Sell
-15,558
Closed -$726K 756
2018
Q3
$726K Buy
15,558
+7,396
+91% +$340K 0.01% 435
2018
Q2
$353K Buy
+8,162
New +$391K 0.01% 441
2018
Q1
Sell
-18,581
Closed -$993K 652
2017
Q4
$993K Buy
+18,581
New +$877K 0.03% 133

Other funds holding MD

Holocene Advisors's MD Position: Q4 2022 in Review

Holocene Advisors sold out of Pediatrix Medical (MD) in Q4 2022, closing a stake of 65,954 shares — an estimated $1.09M sold.

Holocene Advisors first reported a position in MD in Q4 2017 and held it in 17 quarters. The position peaked at $4.07M in Q1 2021. 209 funds tracked by Wall St. Rank hold MD as of Q4 2022.

  • Holocene Advisors reported no remaining Pediatrix Medical position as of Q4 2022 after selling out during the quarter.
  • Holocene Advisors sold 65,954 Pediatrix Medical shares in Q4 2022, an estimated $1.09M.
  • Holocene Advisors first reported a position in Pediatrix Medical in Q4 2017 and held it in 17 quarters.
  • Holocene Advisors's Pediatrix Medical position peaked at $4.07M in Q1 2021.
  • 209 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2022.

Based on Holocene Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.